HMC
Harvard Management Company’s Xilio Therapeutics XLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-416,059
| Closed | -$878K | – | 22 |
|
|
2023
Q3 | $878K | Hold |
416,059
| – | – | 0.1% | 19 |
|
|
2023
Q2 | $1.09M | Hold |
416,059
| – | – | 0.11% | 26 |
|
|
2023
Q1 | $1.32M | Hold |
416,059
| – | – | 0.14% | 37 |
|
|
2022
Q4 | $1.12M | Hold |
416,059
| – | – | 0.14% | 40 |
|
|
2022
Q3 | $1.21M | Hold |
416,059
| – | – | 0.15% | 41 |
|
|
2022
Q2 | $1.22M | Hold |
416,059
| – | – | 0.14% | 39 |
|
|
2022
Q1 | $2.94M | Hold |
416,059
| – | – | 0.3% | 34 |
|
|
2021
Q4 | $6.66M | Buy |
+416,059
| New | +$6.66M | 0.62% | 35 |
|